Daan Gene Co., Ltd. (SHE:002030)
6.71
-0.37 (-5.23%)
Jun 1, 2026, 3:04 PM CST
Daan Gene Market Cap
Daan Gene has a market cap or net worth of 9.42 billion as of June 1, 2026. Its market cap has increased by 24.49% in one year.
Market Cap
9.42B
Enterprise Value
8.67B
Revenue
737.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.71
Market Cap Chart
Since August 9, 2004, Daan Gene's market cap has increased from 1.30B to 9.42B, an increase of 623.48%. That is a compound annual growth rate of 9.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 9.94B | 18.79% |
| Dec 31, 2025 | 8.36B | 4.93% |
| Dec 31, 2024 | 7.97B | -41.32% |
| Dec 29, 2023 | 13.59B | -37.79% |
| Dec 30, 2022 | 21.84B | -22.43% |
| Dec 31, 2021 | 28.15B | -6.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HitGen | 11.84B |
| Inner Mongolia Furui Medical Science | 11.83B |
| Chengzhi | 11.64B |
| InventisBio | 11.28B |
| Hualan Biological Vaccine | 10.72B |
| Chongqing Genrix Biopharmaceutical | 9.83B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.43B |
| Chengdu Easton Biopharmaceuticals | 9.25B |